Ramon Vilallonga
Ramon Vilallonga
Professor
  • :626 42 5858

Department of General Surgery
Universitary Hospital Vall d'Hebron
Spain

Education

Bachelor of Medicine and Surgery Autonomous University of Barcelona
Quality Agency Professor of Surgery Autonomous University of Barcelona
Doctor in Medicine and Surgery Autonomous University of Barcelona

 

Biography

Dr. Vilallonga graduated in general surgery in Vall d'Hebron Hospital in 2008. He trained in IRCAD (Strasbourg, France) with Dr. Jacques Marescaux. Also trained with Dr. Keith Kim (Florida, USA) for robotic bariatric surgery and Dr. Raul Rosenthal in Cleveland Clinic. He developed the robotic bariatric and children program in Vall d'Herbon Hospital. He worked in Belgium with Dr. Jacques Himpens in a high volume center. Currently he is a consultant surgeon in Vall Hebron Hospital exppert in obesity surgery.

 

Research Interest

  • Surgery of the digestive system
  • Robotic and Laparoscopic Surgery
  • Laparoscopic Oncologic Surgery
  • Adrenal thyroid surgery, parathyroid, and pancreatic
  • Endocrine surgery
  • Surgery Soft Tissue Tumors

 

Professional Activities:

Bachelor of Medicine and Surgery from the Autonomous University of Barcelona

2001

Professor at the Autonomous University of Barcelona and Accredited Universities Quality Agency Professor of Surgery

2006

Doctor in Medicine and Surgery from the Autonomous University of Barcelona and Cum Laude with Honors

2004

Residency in General and Digestive Surgery at the Hospital Vall d'Hebron in Barcelona

2003-2008

Specialist in General Surgery and Digestive Diseases

2008

Facutativo Specialist Hospital General Universitario Vall d'Hebron in Barcelona

2008

Accreditation as Resident Tutor

2011

Degree of competition in Morbid Obesity Surgery. (SECO)

2012

Publications

  1. Morphometric study of transbronchial biopsies in pulmonary transplantation. E. Caballero, R. Vilallonga, F. Morell, J. Majó. Virchows Archiv. Oficial Journal of the     European Society of Pathology. 2003Vol 443. Num.3. September 2003.  IF: 2,56
  2. Obstrucción intestinal intermitente y subaguda debida a lipoma gigante de colon. R. Vilallonga,  A. Naval, J. Masferrer, M. Armengol. Med Clin (Barc), 2004, 123(16):6389. IF: 1
  3. Neumoperitoneo idiopático. M. LópezCano, R. Vilallonga, R. Lozoya, JL. SanchézGarcía, E.  Espín, J. Azem, M. Armengol.  Cir Esp.  2005, 78(2):112114.
  4. Exéresis laparoscópica de quiste mesentérico retrocecal. R. Lozoya, M. LópezCano, J.mal Hazme Abderrazek, R.Vilallonga, E. Espín, JL. Sánchez García, M. Armengol. SECLA ENDOSURGERY. Núm.10. EneroMarzo 2005. www.seclaendosurgery.com
  5. LongTerm results of tacrolimus in cyclosporine –and prednisonedependent myasthenia gravis. J.M. Ponseti, J. Azem, J.M. Fort, M. LópezCano, R. Vilallonga, M. Buera, C. Cervera, M. Armengol.  Neurology, May 2005; 64:16411643. IF: 5,07
  6. Intestinal lymphangioma: an unusual cause of small bowel obstruction. R. Vilallonga, E. Espin, M. Armengol. Pakistan Journal of Surgery. Member of WHO regional index medicus. Vol. 21. Issue 2. 2005.
  7. Experience with starting tacrolimus postoperatively after transsternal extended thymectomy in patients with myasthenia gravis. JM. Ponseti, J. Azem, JM. Fort, M. LópezCano, R. Vilallonga, J. Gamez, M. Armengol. Curr Med Res Opin. 2006 May;22(5):88595. IF: 3,06
  8. Apendicectomía en gestantes. R. Vilallonga , M. LópezCano, M. Armengol. Cir Esp. 2006; 79:25961.
  9. Lesiones Retrorectales en adultos. Experiencia en cinco años. M. LópezCano, R. Vilallonga, E. Espin, JL. SánchezGarcia, R. Lozoya, M. Armengol. Cir Esp. 2006; 80(5):3346.
  10. Phenotypic differences between male physicians, surgeons, and film stars: comparative study. R. Vilallonga. BMJ 2006; 333: 12911293. Comunicación electrónica. Respuesta al Artículo aceptada. 2 enero 2007.
  11. La robótica y la cirugía al alcance de nuestras manos virtuales. R. Vilallonga, M. LópezCano, M. Armengol. Cir Esp. 2007; 82(5):3126.
  12. Postthymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complet estable remission in patients with myasthenia gravis: a nonrandomised, noncontrolled study. JM. Ponseti, J. Gámez, J. Azem, J.M. Fort, R. Vilallonga, M. Buera, M. Armengol. Curr Med Res Opin. 2007 Jun;23(6):126978. Epub 2007 Apr 25. IF: 2,96
  13. Les malaties hepàtiques i transplantament: la lluita per viure.  R. Vilallonga Butlletí de la Societat Andorrana de Cièmcies. Núm 131. Maigjuny 2007. (Comentari de conferència).
  14. Short postal questionnaire and selective clinical examination combined with repeat mailing and telephone reminders as a method of followup in hernia surgery. M. LópezCano, R. Vilallonga, JL. Sánchez, E. Hermosilla, M. Armengol. Hernia. 2007,11(5):397402.
  15. Recurrence of Hepatocellular Carcinoma after Liver Transplantation. A. Escartin, G. Sapisochin, I. Bilbao, R.Vilallonga, J. Bueno, L. Castells, C. Dopazo, E. Castro, M. Caralt, J. Balsells. Transplant Proc. 2007 Sep; 39(7):23082310. IF: 1,07
  16. Manejo quirúrgico del estreñimiento crónico grave.  E. Espin, R. Vilallonga, M. Armengol. Cir Esp. 2007 Jul;82(1):545.
  17. Colecistectomia laparoscópica durante la gestación. R. Vilallonga, JJ Olsina, C. Margarit, J.Balsells. Rev Esp Enferm Dig. 2007 Nov;99(11):67980. IF: 1,09
  18. Penetración del colon por catéter de derivación ventrículo peritoneal. R. Vilallonga, F. Vallribera, MJ. Mañas, E. Espin. Cir Esp. 2008 Apr; 83(4):214.
  19. Small bowel metastasis from a nonmicrocytic lung cancer. MJ. Mañas, E. Espin, R. Vilallonga, M. Armengol. Rev Esp Enferm Dig. 2008 Jan; 100(1):6465. IF: 1,26
  20. Neuroendocrine carcinomas of the colon and rectum. A unit’s experience over six years. R. Vilallonga, E. Espin, M. LópezCano, S. Landolfi, M. Armengol. Rev Esp Enferm Dig. 2008 Jan; 100(1):1116. IF: 1,26
  21. Krukenberg's tumor as the first clinical manifestation of fibrolamellar hepatocarcinoma. Bilbao, R. Vilallonga, E. Allende, A. Montero, S. Quiroga, L. Viladomiu, R. Charco y C. Margarit.   Gastroenterol Hepatol. 2008 JunJul;31(6):3416.  IF: 1,26
  22. Myasthenia Gravis and related disorders: 11th International Conference. Henry J. Kaminski. Effectiveness and safety of low dose tacrolimus in a cohorte of 178 thymectomyzed patients with MG. J. Gamez, JM. Ponseti, Guasch, M. LópezCano, J. Azem, R. Vilallonga, M. Armengol. Ann N Y Acad Sci. Vol 1132, June 2008 ISBN 1573316873. page 372.
  23. Tacrolimus for myasthenia gravis: a clinical study of 212 patients. JM. Ponseti, J. Gamez, M. LópezCano, J. Azem, R. Vilallonga, M. Armengol. Ann N Y Acad Sci. 2008;1132:25463. Epub 2007 Dec 20.
  24. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis. JM. Ponseti, J. Gamez, R. Vilallonga, C. Ruiz, J. Azem, M. LópezCano, M. Armengol. Eur J Cardiothorac Surg. 2008 Nov;34(5):10627. IF: 2,18
  25. Colouterine fistula complicating diverticulitis in elderly women.  R. Vilallonga, JA. Baena, JM. Fort, O. González, E. Gemar, M. Armengol  Int J Colorectal Dis. 2009 May; 24(5): 599600. IF: 2,1
  26. A comparison of longterm post thymectomy outcome of anti AChR positive, anti AChR negative and anti MuSK positive patients with nonthymomatous myasthenia gravis. JM. Ponseti, N. Caritg, J. Gamez, M. LópezCano, R. Vilallonga, M. Armengol Expert Opin Biol Ther. 2009 Jan;9(1):18. IF: 3,21
  27. Cavernous Hemangioma: Unusual Benign Tumour of the Transverse Colon R. Vilallonga, E. Espin, M. Armengol. Turkish Journal of Gastroenterology. 2009 Jun;20(2):1469. IF: 0,48
  28. Perforación estercorácea de colon. R. Vilallonga, M. Armengol. Rev Esp Enferm Dig. 2009 Feb;101(2):1467. IF: 0,99
  29. Trasplante intestinal en posición no anatómica R. Charco, C. Malagelada, L. Llopart, J. Bueno, I. Bilbao, M. Caralt, R. Vilallonga, J. Gavaldá, J. Dot, M. Planas, A. Accarino, F. Azpiroz. Rev Esp Enferm Dig. 2009 Feb;101(2):13943. IF: 0,99
  30. MMPs/TIMPs and inflamatory signals deregulation in human incisional hernia tisúes. J. Guillem, R. Diaz, MT. Quiles, M. López, R. Vilallonga, P. Huguet, S. Ramon y Cajal, A. Sanchez, J. Reventós, M. Armengol, MA. Arbós. Journal of Cellular and Molecular Medicine. 2009 NovDec;13(1112):443243. Epub 2008 Dec 29.
  31. Malalties hepàtiques del futur que requeriran cirurgia o transplantament. Recull de conferències i Debats de recerca 2007, ISBN 9789992016800, autors I. Bilbao i R. Vilallonga, Societat Andorrana de Ciències 2008, DOI: 10.2436/15.0110.02.1.
  32. Lipoma of the Uterine Corpus: Exceptional eventuality combined with an ovarian thecoma. R. Vilallonga, A. Garcia, J. Castellví, JM. Fort, M. Armengol, S. Ramón y Cajal. Case Report in Medicine. Volume 2009 (2009), Article ID 340603, 4 pages doi:10.1155/2009/340603.
  33. Risk of death after emergency repair of abdominal wall hernias. Still waiting for improvement. MA. Martínez Serrano, JA. Pereira, JJ. Sancho, M. LópezCano, E. Bombuy, J. Hidalgo; the Study Group of Abdominal Hernia Surgery of the Catalan Society of Surgery. Langenbecks Arch Surg. 2010 Jun;395(5):5516. Epub 2009 Jun 10. IF: 1,95
  34. Single incision laparoscopic surgery (SILS) cholecystectomy. A novel technique R. Vilallonga, RA. Stoica, A. Cotirlet, M. Armengol, N. Iordache Chirurgia. 2010; 105(2): 239241. IF: 0,66
  35. Gastrointestinal Stromal Tumor: Cause of Gastrointestinal Bleeding. R. Vilallonga, JL. Sanchez, M. Armengol Gastroenterology Research. ISSN 19182805 print, 19182813 online. Volume 3, Number 2, April 2010, pages 9395
  36. Endoscopic Management of Drain Inclusion in the Gastric Pouch after Gastrojejunal Leakage after Laparoscopic RouxenY Gastric Bypass for the Treatment of Morbid Obesity (LRYGBP). R. Vilallonga, JM. Fort, O. González, J.A. Baena, A. Lecube, J. Salord, M. Armengol, JR, ArmengolMiró. Diagn Ther Endosc. 2010;2010:891345. Epub 2010 Jun 20.
  37. Translocation of an intrauterine contraceptive device: incidental finding in the rectosigmoid colon. R. Vilallonga, N. Rodriguez, M. Vilchez, M. Armengol.  Obstet Gynecol Int. 2010;2010:404160. Epub 2010 Jun 9.  IF: 4,39
  38. Rotura esplénica después de fibrocolonoscopia. Complicación excepcional. R. Vilallonga, JR. Armengol, JA. Baena, J. Dot, M. Armengol  Cir Esp. 2010 Jan;87(1):578.
  39. Hernia de Littré: Hallazgo inusitado en la reparación de una hernia inguinoescrotal. A. Biel, R. Vilallonga, I. López de Cenaruzabeitia, N. Rodriguez, M. Armengol  Rev Esp Enferm Dig. 2010 Jul;102(8):5067.  IF: 1,13
  40. Respuesta a los autores Jesús Garijo Álvarez, José Daniel Sánchez López a, Tomás González Elosua a, Martín Gascón Hove b, Luis GarcíaSancho Téllez et al. por el artículo Colecistectomía laparoscópica transumbilical. Resultados con el dispositivo de gel y revisión de la literatura. publicado en Cir Esp. 2010;87:2938. R. Vilallonga, JM Fort, M Armengol.  Cir Esp. 2010 Oct;88(4):2778; author reply 2789. Epub 2010 Aug 11.
  41. Rightsided diaphragmatic rupture after blunt trauma. An unusual entity.  R. Vilallonga, V. Pastor, L. Alvarez, R. Charco, M. Armengol, S. Navarro. World J Emerg Surg. 2011 Jan 18;6:3. PubMed PMID: 21244704.
  42. Management of patients with hernia or incisional hernia undergoing surgery for morbid obesity. R. Vilallonga, JM. Fort, O. González, JA. Baena, A. Lecube, M. Armengol. J Obes. 2011;2011:860942. Epub 2010 Dec 5. PubMed PMID: 21188167.
  43. Single port access sleeve gastrectomy: Is it reasonable? R. Vilallonga, J. Rius, J.M. Fort, M. Armengol. J Min Access Surg. 2011 Apr;7(2):1567
  44. Singleport transumbilical laparoscopic cholecystectomy:a prospective randomized comparison of clinical results of 140 cases. R. Vilallonga, U. Barbaros, A. Sümer, T. Demirel, JM. Fort, O. González, N. Rodriguez, M. Armengol.  J Min Access Surg. 2012 Jul;8(3):748.
  45. Isolated Langerhans Cell Histiocytosis of the Thyroid in an Adult Female: OneYear Followup. R. Vilallonga, A. Ciudin, J.M. Fort, JA. Baena, O. González, M. Armengol, J. Mesa, MC. Ruiz Marcellán. International Journal of Endocrinology. Volume 2011, Article ID 898302. doi:10.1155/2011/898302. IF: 1,39
  46. A giant euthyroid endemic multinodular goiter with no obstructive or compressive symptoms. A. Nada, A. Mohamed, R. Vilallonga, M. Armengol, I. Mustafa. Case Rep Med. 2011;2011:620480.doi:10.1155/2011/620480.Epub 2011 Jun 13.
  47. Severe hyponatremia in postoperatory of papillary thyroid carcinoma as a manifestation of acute intermittent porphyria.  MJ. Mañas, O. González, R. Vilallonga, M. Armengol. Med Clin (Barc). 2011 Apr 30;136(12):5567.  IF: 1,39
  48. Empiema Necessitatis en paciente añosa. Una rara entidad en la actualidad. MA. Boleko,A. Biel, D. Andrada, R. Vilallonga, M. Armengol. Rev Esp Enferm Dig. 2012 Feb;104(1):423. IF: 1,65
  49. Giant intrathyroidal parathyroid adenoma. Study of a case. R. Vilallonga, C. Zafón, R. Migone, JA. Baena. J Emerg Trauma Shock. 2012 Apr;5(2):1968.
  50. Intestinal occlusion as unusual complication of new intragastric balloon Spatz Adjustable Balloon system for treatment of morbid obesity.  R. Vilallonga, S. Valverde, E. Caubet. Surg Obes Relat Dis. 2013 JanFeb;9(1):e167. IF: 4,94
  51. Renaissance of acromegaly after bariatric surgery.  A. Lecube, R. Vilallonga, G. Sturniolo, G. Obiols, JM. Fort.  Endocrine. 2013 Feb;43(1):2394 IF: 3,53
  52. Use of images in a surgery consultation. Will it improve the communication? R. Vilallonga, JM. Fort, N. Iordache, M. Armengol, X. Clèries, M. Solà  Chirurgia(Bucur). 2012 MarApr;107(2):2137 IF: 0,52
  53. Single port transumbilical laparoscopic appendectomy: a preliminary multicentric comparative study in 87 patients with acute appendicitis. R. Vilallonga, U. Barbaros, A. Nada, A. Sümer, T. Demirel, JM. Fort, O. González, M. Armengol. Minim Invasive Surg. 2012;2012:492409. Epub 2012 May 13.
  54. The Initial Learning Curve for RobotAssisted Sleeve Gastrectomy: A Surgeon's Experience While Introducing the Robotic Technology in a Bariatric Surgery Department.  R. Vilallonga, JM. Fort, O. González, E. Caubet, A. Boleko, KJ. Neff, M. Armengol. Minim Invasive Surg. 2012;2012:347131. doi: 10.1155/2012/347131.
  55. 55.  Jejunal diverticula causing massive intestinal bleeding.  R. Vilallonga, JL. Sanchez Garcia, M. Armengol, N. Iordache   Chirurgia (Bucur). 2012 SepOct;107(5):6524. IF: 0,52
  56. Postthyroidectomy Horner's Syndrome.  R. Vilallonga, JM. Fort, A. Mazarro, O. González, E. Caubet, G. Romero, M. Armengol.  Case Report Med. 2012; 2012:316984. doi: 10.1155/2012/316984.
  57. Bariatric surgery in adolescents. R. Vilallonga, D. Yeste, A. Lecube, JM. Fort  Cir Esp. 2012 Dec;90(10):619625. Nov 6. IF: 0,87
  58. A bariatric surgery programme in adolescents. Preliminary results.  R. Vilallonga, D. Yeste, A. Lecube, M. Armengol,  JM. Fort. Cir Esp. 2013 Dec;91(10):6857 IF: 0,89
  59. Internet of Things and bariatric surgery followup: Comparative study of standard and IoT followup.  R. Vilallonga, A. Lecube, JM. Fort, MA. Boleko, M. Hidalgo, M. Armengol.  Minim Invasive Ther Allied Technol. 2013 Sep;22(5):30411 IF: 1,18
  60. Laparoscopic repair of a postadrenalectomy leftsided diaphragmatic hernia complicated by chronic colon obstruction.  R. Vilallonga, E. Caubet, O. González, KJ. Neff, JM. Fort, A. Mazarro, M. Armengol. Surg Endosc. 2013 May;27(5):18268. IF: 3,31
  61. Bariatic Surgery outcomes in a European Center of Excellence. (CoE) JM. Fort, R. Vilallonga, A. Lecube, O. González, E. Caubet, J. Mesa, M. Armengol. Obes surg. 2013 Aug;23(8):132432. doi: 10.1007/s1169501309805. IF: 3,74
  62. Reply to the article Moszkowicz D, Arienzo R, Khettab I, Rahmi G, Zinzindohoué F, Berger A, Chevallier JM. Sleeve gastrectomy severe complications: Is it always a reasonable surgical option? Obes Surg. 2013 Feb 12. R. Vilallonga, van de Vrande, Himpens J, Leman G Obes Surg.2013 Oct;23(10):16756. doi: 10.1007/s1169501309832. IF: 3,74
  63. Hybrid endolaparoscopic management of biliary tract pathology in bariatric patients after gastric bypass. Case report and review of a single institution experience. R. Vilallonga, Pimenrel R, Rosenthal R. Surg Laparosc Endosc Percutan Tech. Oct;23(5):e18890. doi: 10.1097/SLE.0b013e31828b85e8. IF: 0,94
  64. A Hybrid endoLaparoscopic Therapy for the treatment of foreign bodies in the stomach with oesophageal perforation. R. Vilallonga, Pimenrel R, Rosenthal R. Surg Laparosc Endosc Percutan Tech. 2013 Jun;23(3):33740. doi: 10.1097/SLE.0b013e31828e3740. IF: 0,94
  65. Laparoscopic Management of Persistent Strictures After Laparoscopic Sleeve Gastrectomy. R. Vilallonga, J. Himpens, S. van de Vrande.  Obes Surg. 2013; 23(10): 165561. doi: 10.1007/s1169501309930. IF: 3,74
  66. Malignant Thyroid Teratoma: Report of  an Aggressive Tumor in a 64YearOld Man. R. Vilallonga, C. Zafon, C. RuizMarcellan, G. Obiols,  JM. Fort, JA. Baena, B. Villanueva, A. Garcia, M. SobrinhoSimões.  Endocr Pathol. 2013;24(3):1325. doi: 10.1007/s1202201392502. IF: 1,64
  67. Robotic Sleeve Gastrectomy Versus Laparoscopic Sleeve Gastrectomy: a Comparative Study with 200 Patients. R. Vilallonga,  JM. Fort, E. Caubet, O. González, M. Armengol. Obes Surg. 2013 Oct;23(10):15017. doi: 10.1007/s1169501310393. IF: 3,74
  68. Laparoscopic reversal of RouxenY gastric bypass into normal anatomy with or without sleeve gastrectomy.  R. Vilallonga, S. van de Vrande, J. Himpens.  Surg Endosc. 2013 Dec;27(12):46408. doi: 10.1007/s0046401330870.  IF: 3,31
  69. SPECT/CT sentinel lymph node identification in papillary thyroid cancer: lymphatic staging and surgical management improvement.  A. GarciaBurillo, I. Roca Bielsa, O. González, C. Zafon, M. Sabate, J. Castellvi, X. Serres, C. Iglesias, R. Vilallonga, E. Caubet,  JM. Fort, J. Mesa, M. Armengol, J. CastellConesa.  Eur J Nucl Med Mol Imaging. 2013 Oct;40(11):164555 IF: 5,22
  70. Pilot study comparing the leak pressure of the sleeved stomach with and without reinforcement. J. LópezMonclova, ET. Soler, CB. Ponz, R. Vilallonga, K. RodríguezGómez, M. BaezaVitolas. Surg Endosc. 2013 Dec;27(12):472130 IF: 3,31
  71. Reply to the article Espinós JC et al. Early Experience with the Incision less Operating Platform™ (IOP) for the Treatment of Obesity: The Primary Obesity Surgery Endolumenal (POSE) Procedure. R. Vilallonga, Himpens J.  Obes Surg. 2013;23:137583. Obes Surg. 2013 Dec 18.  IF: 3,74
  72. Past and Present in abdominal surgery managment for cushing’s syndrome. R. Vilallonga, Zafon C,  JM. Fort, J. Mesa, M. Armengol. SAGE Open Medicine. DOI: 10.1177/2050312114528905
  73. Can LigaSure™ be used to perform sleeve gastrectomy?  Tensile strength and histological changes.  J. López, R. Vilallonga, EM. Targarona, C. Balague, L. Enriquez, R. Rivera, JM. Balibrea, F. PerezOchoa, K. Rodriguez, M. Baeza, A. Reyes  Minim Invasive Ther Allied Technol. 2014 Jun;23(3):14451 IF:1,18
  74. Reply to the Article Ben Yaacov A, Sadot E, Ben David M, Wasserberg N, Keidar A. Laparoscopic total gastrectomy with Rouxy esophagojejunostomy for chronic gastric fistula after laparoscopic sleeve gastrectomy.  R. Vilallonga, J. Himpens, S. van de Vrande. Obes Surg. 2014 Mar;24(3):4259IF:3,74
  75. Informe del estudio Delphi para determinar el grado de acuerdo en el manejo nutricional del paciente quirúrgico.  Martin E, Soria V, Álvarez J, del Olmo D y grupo de trabajo. Ciencia y Evidencia (ISSN 21748101). Vol 4, julio 2014: 312.
  76. Decreased lipases and fatty acid and glycerol transporter could explain reduced fat in diabetic morbidly obese. R. Ferrer, E. Pardina, J. Rossell, JA. BaenaFustegueras, A. Lecube, JM. Balibrea, E. Caubet, O. González, R. Vilallonga,  JM. Fort, J. PeinadoOnsurbe. Obesity (Silver Spring). 2014 Nov;22(11):237987. doi: 10.1002/oby.20861.IF:4,39
  77. Chronic fistula after gastrectomy vertical laparoscopic. R. Vilallonga,  JM. Fort, J. Himpens. Cir Esp. 2014;92(10):7001. doi: 10.1016/j. IF:0,89
  78. Reply to safety of Veress needle insertion in laparoscopic bariatric surgery.  R. Vilallonga, J. Himpens.  Surg Laparosc Endosc Percutan Tech. 2014 Jun;24(3):283. IF:0,94
  79. Haematological parameters and serum trace elements in "healthy" and "unhealthy" morbidly obese patients before and after gastric bypass.  R. Ferrer, E. Pardina, J. Rossell, JA. BaenaFustegueras, A.Lecube, JM. Balibrea, E. Caubet, O. González, R. Vilallonga, JM. Fort, J. PeinadoOnsurbe.  Clin Nutr. 2014 Apr 24. pii: S02615614(14)000934.IF:3,94
  80. Acute pancreatitis during pregnancy, 7year experience of a terciary referral center. R. Vilallonga, A. CaleroLillo, R. Charco, J. Balsells. Cir Esp. 2014 August September; 92(7): 468471. IF:0,89
  81. Evolution of differentiated thyroid cancer: a decade of thyroidectomies in a single institution. C. Zafon, JA.Baena, J. Castellví, G.Obiols, O. González, JM. Fort, R. Vilallonga, E. Caubet, M. Armengol, J. Mesa. Eur Thyroid J. 2014 Sep;3(3):197201. doi: 10.1159/000365416.
  82. Detection of Thyroid Papillary Carcinoma Lymph Node Metastases Using One Step Nucleic Acid Amplification (OSNA): Preliminary Results. O. González, C. Iglesias, C. Zafon, J. Castellví , A. GarcíaBurillo, J.Temprana, E. Caubet, R. Vilallonga, J. Mesa , SR. Cajal, JM. Fort ,M. Armengol, JM. Balibrea J Invest Surg. 2015 Jun;28(3):1539 IF:1,16
  83. Morbidly "Healthy" Obese Are Not Metabolically Healthy but Less Metabolically Imbalanced Than Those with Type 2 Diabetes or Dyslipidemia. Ferrer R, Pardina E, Rossell J, Oller L, Viñas A, BaenaFustegueras JA, Lecube A, Vargas V, Balibrea JM, Caubet E, González O, Vilallonga R, Fort JM, PeinadoOnsurbe J. Obes Surg. 2015 Aug;25(8):138091IF:3,74
  84. European Association of Endoscopic Surgeons (EAES) consensus statement on the use of robotics in general surgery. A. Szold, R. Bergamaschi, I. Broeders, J. Dankelman, A. Forgione, T. Langø, A. Melzer, Y. Mintz, S. MoralesConde, M. Rhodes, R. Satava, CN. Tang, R. Vilallonga. Surg Endosc. 2015 Feb;29(2):25388. doi: 10.1007/s0046401439169. IF:3,31
  85. Laparoscopic treatment of intussusception. R. Vilallonga, J. Himpens, F. Vandercruysse. Int J Surg Case Rep. 2015;7C:324. doi: 10.1016/j.ijscr.2014.10.085 IF:1,65
  86. Laparoscopic Roux limb placement for the management of chronic proximal fistulas after sleeve gastrectomy: technical aspects.  R. Vilallonga, J. Himpens, S. van de Vrande. Surg Endosc. 2015;29(2):4146. doi: 10.1007/s0046401436846. IF:3,31
  87. Robotically Assisted Single Anastomosis Duodenoileal Bypass after Previous Sleeve Gastrectomy Implementing High Valuable Technology for Complex Procedures. R. Vilallonga, JM Fort, E. Caubet, et al.,  Journal of Obesity, vol. 2015, Article ID 586419, 6 pages, 2015. doi:10.1155/2015/586419
  88. Metabolic consequences of the incorporation of a Roux limb in an omega loop (mini) gastric bypass. Evaluation by a glucose tolerance test at midterm followup. J. Himpens, R. Vilallonga, GB Cadière, G Leman. Surg Endosc. 2015; Set. Accepted forpublication. IF: 3,31
  89. Reply to Blot C et al. “Conservative surgical management of persistent leak after sleeve gastrectomy by RouxenY gastrojejunostomy to the fistulous orifice”. R. Vilallonga, N. Mahendra. Journal of Visceral Surgery. 2015; Set. Accepted forpublication. IF: 1,75
  90. Bariatric surgery acutely changes the expression of inflammatory and lipogenic genes in obese adipose tissue. FJ. Ortega, R. Vilallonga, G. Xifra, M. Sabater, W. Ricart, JM Fernándrez Real. Surg Obes Relat Dis. 2013 JanFeb;9(1):e167. IF: 4,94
  91. Role of Percutaneous Glue Treatment After Persisting Leak After Laparoscopic Sleeve Gastrectomy. J. Himpens, R. Vilallonga, J. Himpens, B Bosch, S van de Vrande. Obes Surg. 2015 Nov; IF:3,74
  92. Comment on (Panniculectomy Combined with Bariatric Surgery R. Vilallonga Surgery Research and Practice Volume 2016, Article ID 9709283, 2 pages
  93. Diabetic and dyslipidaemic morbidly obese exhibit more liver alterations compared with healthy morbidly obese. Eva Pardina, Roser Ferrer, Joana Rossell, Juan Antonio BaenaFustegueras, Albert Lecube, Jose Manuel Fort, Enric Caubet, O´ scar Gonza´lez, Ramo BBA CLINIC. 2016
  94.  

Heart Health Journal Flyer